Ftse Mib
34.375,92
0,00%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
64.056,97
-1,23%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
23/06/202322:41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APLTApplied Therapeutics Inc
22/06/202313:00GlobeNewswire Inc.Applied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes AssociationNASDAQ:APLTApplied Therapeutics Inc
16/06/202322:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
15/06/202313:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve SocietyNASDAQ:APLTApplied Therapeutics Inc
25/05/202313:00GlobeNewswire Inc.Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD DeficiencyNASDAQ:APLTApplied Therapeutics Inc
22/05/202312:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APLTApplied Therapeutics Inc
19/05/202322:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APLTApplied Therapeutics Inc
11/05/202313:00GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
10/05/202318:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
05/05/202322:55Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:APLTApplied Therapeutics Inc
28/04/202322:46Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
24/04/202313:00GlobeNewswire Inc.Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA SubmissionNASDAQ:APLTApplied Therapeutics Inc
24/04/202313:00GlobeNewswire Inc.Applied Therapeutics, Inc. Announces $30 Million Private Placement of EquityNASDAQ:APLTApplied Therapeutics Inc
17/04/202323:29Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:APLTApplied Therapeutics Inc
17/04/202322:40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APLTApplied Therapeutics Inc
17/04/202322:40Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APLTApplied Therapeutics Inc
23/03/202312:54Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APLTApplied Therapeutics Inc
23/03/202312:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APLTApplied Therapeutics Inc
23/03/202311:30GlobeNewswire Inc.Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
01/03/202313:00GlobeNewswire Inc.Applied Therapeutics to Present at the Cowen 43rd Annual Health Care ConferenceNASDAQ:APLTApplied Therapeutics Inc
16/02/202313:00GlobeNewswire Inc.Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) DeficiencyNASDAQ:APLTApplied Therapeutics Inc
14/02/202320:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APLTApplied Therapeutics Inc
09/02/202313:00GlobeNewswire Inc.Applied Therapeutics to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APLTApplied Therapeutics Inc
13/01/202322:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
04/01/202312:00GlobeNewswire Inc.Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in EuropeNASDAQ:APLTApplied Therapeutics Inc
14/11/202204:55TipRanksRobert W. Baird Remains a Buy on Applied Therapeutics (APLT)NASDAQ:APLTApplied Therapeutics Inc
09/11/202213:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
09/11/202213:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2022 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
31/10/202212:00GlobeNewswire Inc.Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022NASDAQ:APLTApplied Therapeutics Inc
27/10/202207:55TipRanksApplied Therapeutics (APLT) Receives a Buy from Robert W. BairdNASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

EU
GBT
Guerbet
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network